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Abstract
Trigeminal neuralgia is a disorder associated with severe episodes of lancinating pain in the distribution of the trigeminal nerve. Previous reports
indicate that 80-90% of cases are related to compression of the trigeminal nerve by an adjacent vessel. The majority of patients with trigeminal
neuralgia eventually require surgical management in order to achieve remission of symptoms. Surgical options for management include ablative
procedures (e.g., radiosurgery, percutaneous radiofrequency lesioning, balloon compression, glycerol rhizolysis, etc.) and microvascular
decompression. Ablative procedures fail to address the root cause of the disorder and are less effective at preventing recurrence of symptoms
over the long term than microvascular decompression. However, microvascular decompression is inherently more invasive than ablative
procedures and is associated with increased surgical risks. Previous studies have demonstrated a correlation between surgeon experience and
patient outcome in microvascular decompression. In this series of 59 patients operated on by two neurosurgeons (JSN and PEK) since 2006,
93% of patients demonstrated substantial improvement in their trigeminal neuralgia following the procedure—with follow-up ranging from 6 weeks
to 2 years. Moreover, 41 of 66 patients (approximately 64%) have been entirely pain-free following the operation.
In this publication, video format is utilized to review the microsurgical pathology of this disorder. Steps of the operative procedure are reviewed
and salient principles and technical nuances useful in minimizing complications and maximizing efficacy are discussed.
Protocol
1. Positioning
2. Incision
3. Craniotomy and dural opening
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1. Positioning is an integral component of microvascular decompression. Following induction of anesthesia, the patient is placed in pins while on
the operating room table and moved to the lateral park bench position with side of the desired MVD placed up. Of note, JSN prefers to insert
a lumbar drain prior to the procedure to allow greater control of intra-op drainage of CSF and cerebellar relaxation (the drain is then removed
when the patient is discharged, often on POD2).
2. All pressure points are padded and an axillary roll is placed. The patient's chest and hips are taped securely to the table to allow rotation of
the table, if necessary, later in the case. The patient's shoulder is taped down for purposes of visualization. The head is rotated approximately
10-15 degrees away from the affected side and the neck is flexed slightly so that the planned surgical trajectory is now almost orthogonal to
the floor. The vertex is tilted slightly down. Special attention is made to ensure that there no pathologic compression of venous drainage from
the head. Specifically, there should be room for at least two finger breadths between the mandible and upper thorax. Head rotation should not
exceed 30 degrees.
3. c. The body is secured prior to three-point head fixation. Electrophysiologic monitoring (brainstem auditory evoked response and facial nerve
monitoring) is then secured. Stealth navigation, if used, is registered.
1. Prior to prepping and draping, external landmarks are assessed. It is helpful to draw the inion-meatal line with an indelible marker. The
iniomeatal line is drawn out first with an indelible marker. This dotted line represents the superficial representation of the location of the
transverse sinus. Next, a dotted line is drawn overlying the course of the digastric groove. The portion of this line inferior to the iniomeatal line
represents a superficial representation of the location of the sigmoid sinus.
2. A curvilinear incision is drawn out approximately two fingerbreadths behind the pinna for the length of the ear. The patient is prepped and
draped in the usual fashion.
3. Using a scalpel, the aforementioned incision is deepened. Dissection is carried down to the bone using a scalpel and monopolar cautery.
Self-retaining retractors are placed.
1. With the superficial representation of the junction of the transverse and sigmoid sinuses in mind, drilling is initiated.
2. PEK prefers to drill the bone away to expose the transverse-sigmoid junction. A 3-cm craniectomy defect is usually created for access to the
CP angle. This method avoids the possible risk posed by use of a drill with a footplate adjacent to the venous sinuses, potentially resulting in
a dural sinus laceration.
3. JSN prefers to use a perforator drill for burr hole placement at the level of the transverse-sigmoid junction. Following this, a 3-cm craniotomy
bone flap is created and set aside for replacement at the end of the case. The drill is then used to expose the remainder of the transverse and
sigmoid sinuses. This method allows for replacement of the bone flap following the microvascular decompression.4. Exposure of the cerebellopontine angle
5. Decompression of the trigeminal nerve
6. Closure
7. Representative Results
Using a review of CPT codes obtained from the VUMC Billing Department, the medical records of 59 patients who underwent microvascular
decompression by one of two functional neurosurgeons (JSN or PEK) at Vanderbilt University Medical Center (VUMC) from the period of time
from July 2006 to July 2009 were assessed in a retrospective fashion. Study data were collected and managed using REDCap electronic data
capture tools2 (REDCap is a secure, web-based application based at Vanderbilt University designed to support data capture for research
studies). A summary of the demographics of this patient population is visible in Table 1.
Regarding patient demographics (see Table 1), approximately 66% of patients were female. 10% had a history of multiple sclerosis and 19% had
a history of previous surgical procedures for TGN (Table 2). Regarding operative results (see Table 3), 93% of patients experienced significant
improvement or full resolution of the facial pain at follow-up ranging from 6 weeks to 2 years. Our method of follow-up consisted of a retrospective
review of the electronic medical record. 64% of patients reported themselves as pain-free at their most recent clinic visit following the procedure.
Approximately 15% of patients in the series suffered a CSF leak; 6 (10%) of these patients required ventriculoperitoneal shunt insertion (VPSI).
Of note, the rate of CSF leak was appreciably higher in the patient population prior to the routine use of bone flap or methylmethacrylate (MM)
buttressing of closure. Specifically, 25% of patients who were closed without a bone flap or methylmethacrylate prosthetic flap developed a CSF
leak. In contrast, only 8% of patients closed after bone or MM flap placement had evidence of post-operative CSF leakage. In addition to the
results described above, Two (3%) of patients suffered a wound infection. There were no instances of cerebellar damage. Two (3%) of patients
reported some degree of post-operative hearing loss.
Table 1. Summary of patient demographics.
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4. Once the transverse and sigmoid sinuses have been exposed extradurally, the bone edges are waxed thoroughly. It is important to drill far
enough laterally to allow proper dural reflection and visualization. When the mastoid air cells are encountered, they are vigorously waxed.
5. The dura is opened in a stellate fashion. The dural leaves are tacked up using 4-0 Nurolon and the dural incision is taken as close to the
transverse-sigmoid junction as possible. This allows visualization of a corridor directly adjacent to the junction of the tentorium and petrous
temporal bone.
1. After the dura has been reflected and sutured, a Leyla retractor is placed with telfa underlying the retractor. The cerebellum is elevated and
gently retracted medially. Using suction and bipolar electrocautery, CSF is allowed to egress-resulting in gentle relaxation of the cerebellum.
2. With the cerebellum now having fallen away from the petro-tentorial junction, the retractor is advanced with further gentle elevation of the
cerebellum. The superior petrosal vein complex is taken when necessary. When the petrosal vein is sacrificed, coagulation with bipolar
cautery is followed by partially division with microscissors. The vessel is then further coagulated and then fully transected to ensure there is
no hemorrhage following vessel ligation.
3. As "the corner is turned" and the cerebellopontine angle is exposed, the VII-VIII nerve complex is visualized first. During this exposure,
vigilant attention is given to BAER (brainstem auditory evoked response) and facial nerve monitoring to guard against retraction injury.
Superior and medial to the VII-VIII nerve complex, the trigeminal nerve is then visualized.
1. Microscissors are used to open the arachnoid around the trigeminal nerve. Sharp dissection is necessary so that the nerve and superior
cerebellar artery (SCA) can be inspected circumferentially. Inspection of the trigeminal nerve begins at the site of brainstem exit and proceeds
laterally.
2. The most common vessel found in trigeminal neuralgia is a rostroventral loop of the SCA1. This vessel was the causal agent of compression
in 53% of patients in this series.
3. After the causative vessel is identified, dissected, and freed, the vessel loop is mobilized away from the nerve. A small piece of Teflon is then
placed underneath the vessel-elevating it off the trigeminal nerve.
4. Following decompression, the nerve is reexamined on all sides to be certain that no additional compressing vessels are present.
1. The wound is irrigated with saline and all retractors are removed. The dura is then closed using a running 4-0 Nurolon.
2. The remaining steps of closure differ slightly between attending. For JSN, the patch of the pericranium taken at the beginning of the case can
be used to assist with water-tight closure of the dura. Multiple tacking holes are placed in the bone and 4-0 Nurolons are passed from the
edge of the dura through the tacking holes and secured. Surgicel and Gelfoam are placed on top of the dura, and the bone flap is replaced
with KLS screws and plates. Norian bone cement is then used to close off the remainder of the cranial opening in order to prevent later
insertion of the muscle onto the dura. The wound is then copiously irrigated with Bacitracin irrigation and closed in layers with 2-0 Vicryls in
multiple layers in the muscle, 3-0 Vicryls in the galea and dermis, and a running 4-0 Monocryl in the skin.
3. PEK prefers a slightly different method of closure. Following reapproximation of the dura, a piece of Gelfoam is placed overlying the dural
incision. Methyl methacrylate is used to fill in the cranial defect and a small KLS plate used to secure the methylmethacrylate prosthetic to the
skull. The skin and muscle is then closed as described above and covered with bacitracin ointment.
Patient Demographics
Gender (Male/Female) 20/39
History of Multiple Sclerosis (Yes/No) 6/53
History of previous surgical procedures for TGN (Yes/No) 11/48
Previous Procedures (11/59)
Type Number Results: Pain free (PF) vs. Significantly improved (SI) vs. No improvement (NI)
Gamma knife 5 (8%) 3 PF, 2 SITable 2. Surgical outcomes of patients who underwent previous procedures prior to undergoing microvascular decompression (MVD) in the
current series. Patients are stratified by the specific prior procedure. RFL = radiofrequency lesioning.
Table 3. Summary of surgical outcome and complications.
Figure 1. Operative results: rate of post-operative CSF leakage found to be heavily influenced by whether or not closure was buttressed with
bone flap replacement or placement of methylmethacrylate (MM) flap. As a result, bone/MM flap replacement of craniectomy defect is now
standard protocol for closure of these procedures.
Figure 2. Stratification of results describing post-operative improvement in pain.
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MVD 2 (3%) 2 PF
RFL 1 (2%) PF
Multiple procedures 2 (3%) PF, SI
Surgical Outcome and Complications
Average length of follow-up 4 months
Pain significantly improved or resolved entirely 55 (93%)
CSF leak 9 (15%)
Aseptic meningitis 8 (14%)
Wound infection 2 (3%)
Cerebellar damage 0 (0%)
Hearing loss 2 (3%)Discussion
Trigeminal neuralgia is a disorder associated with intense episodes of lancinating pain in the distribution of the trigeminal nerve. The severity of
this pain can result in significant patient anxiety, malnutrition and even depression3. While possible proximal etiologies of this condition are
diverse and include neoplasm or demyelination, 80-90% of cases are related to compression of the trigeminal nerve by an adjacent vessel4,5. In
many cases of trigeminal neuralgia, pharmacological treatment is sufficient for adequate control of symptoms. However, the majority of patients
require more definitive surgical measures6. Both microvascular decompression (MVD) and ablative procedures (e.g., radiosurgery, percutaneous
radiofrequency lesioning, balloon compression, or glycerol rhizolysis) have been shown to be effective at controlling trigeminal neuralgia
symptoms acutely—however, MVD has been demonstrated to be superior in preventing long-term recurrence7.
Since the first reported uses of MVD by Janetta in the 1960s, adaptations to the procedure have improved patient outcomes. The use of
intraoperative auditory brainstem evoked potentials, in particular, has lessened surgical morbidity by monitoring for early irritation of the brainstem
and cranial nerves and assisting in prevention of damage to these structures8. Recent reports estimate positive outcome rates of MVD for
trigeminal neuralgia in the ranges of 77-94%9,10,11
. Nevertheless, significant postoperative complications, namely CSF leak, cerebellar damage
and hearing loss9,10, still occur with the procedure. Additionally, recurrence of symptoms has been reported to occur in as many as 39% of
patients10,11
following this procedure. In addition to being correlated with intraoperative variables such as nerve location, blood vessel, type and
duration of symptoms6,7, the rate of recurrence also has been correlated with experience of the surgeon and hospital in performing MVD12. With
proper technique, patient outcome can be maximized and adverse outcomes can be reduced.
This study examined the effectiveness of the surgical technique of MVD performed by two neurosurgeons at Vanderbilt University. The positive
outcome rate we measured (93%) is at the high range of those generally reported in the literature9,10. While average duration of follow-up in this
series is small, patients are routinely not seen in clinic following the 6-week visit if they remain pain-free and asymptomatic. Given that 64% of
patients reported themselves to be entirely pain-free following the procedure, it is not surprising that the average duration of follow-up in this study
is short. Present complication rates at our institution are comparable to those reported by others. Initially, MVDs were performed with a
suboccipital craniectomy without replacement of the bone flap. After an internal review of the data, which demonstrated an elevated CSF leak of
25%, the protocol was changed to include buttressing with either a methylmethacrylate flap or replacement of the bone flap prior to wound
closure. Since this time, our CSF leak rate has approximated 8%—consistent with other rates (2.4 – 12%) reported in the literature7,13. The
percentage of our patients reporting hearing loss (3%) also approximates figures reported in the literature (0.8-2.8%)1,2,12,13, . In no instance did
we have a patient with evidence cerebellar damage.
Our experience suggests that monitoring with BAERs and bone flap replacement are worthwhile options in microvascular decompression. The
salient surgical principles and technical nuances utilized at Vanderbilt University have been presented in video format. Furthermore, this video
journal format uniquely presents the vascular pathology that many physicians do not routinely see outside the operating room. The results
presented suggest that microvascular decompression can be a highly effective procedure performed with low patient morbidity.
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